The Globe & Mail visited the lab operated by our subsidiary Psilo Scientific and interviewed our team regarding MDMA and the Special Access Program.
Recent News
Labs race to make pharmaceutical MDMA available to treat mental illness
The Globe & Mail
April 15, 2023
